Wine, Wheels and Team Spirit
The Daelemans Lab, together with the research group of Christophe Pannecouque and the SELECT platform, recently came together for a memorable Movion team-building day at Petrushoeve, a picturesque vineyard in the Belgian countryside. The day started with a guided tour of the estate, where we learned more about the art of wine making and the […]
Lore Willem represents the Daelemans Lab at the 4th International Meeting on Arboviruses and their Vectors
The conference brought together researchers working on arboviruses and their vectors from around the world. Over several days, participants shared new findings, discussed emerging challenges, and explored the latest developments in the field. During the meeting, Lore presented a poster on her research. The event offered a valuable opportunity to exchange ideas, gain new insights, […]
Novel reversible XPO1 inhibitor demonstrates potent anticancer activity
Our newest research has been published in Nature Communications: โPreclinical characterization of a reversible XPO1 inhibitor for cancer therapyโ Exportin 1 (XPO1) is a clinically validated anticancer target that plays a key role in transporting proteins from the nucleus to the cytoplasm. Inhibiting XPO1 can trigger cancer cell death, but currently available inhibitors are often […]
New insights into oncolytic virus selection for glioblastoma treatment
Our latest research is published in ๐๐ฐ๐ญ๐ฆ๐ค๐ถ๐ญ๐ข๐ณ ๐๐ฉ๐ฆ๐ณ๐ข๐ฑ๐บ ๐๐ฏ๐ค๐ฐ๐ญ๐ฐ๐จ๐บ:“๐๐จ๐ฆ๐ฉ๐๐ซ๐๐ญ๐ข๐ฏ๐ ๐๐ฏ๐๐ฅ๐ฎ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐จ๐ง๐๐จ๐ฅ๐ฒ๐ญ๐ข๐ ๐ฏ๐ข๐ซ๐ฎ๐ฌ๐๐ฌ ๐ซ๐๐ฏ๐๐๐ฅ๐ฌ ๐จ๐ฉ๐ฉ๐จ๐ฌ๐ข๐ง๐ ๐ฉ๐ซ๐๐๐๐ซ๐๐ง๐๐๐ฌ ๐๐จ๐ซ ๐ ๐ฅ๐ข๐จ๐๐ฅ๐๐ฌ๐ญ๐จ๐ฆ๐ ๐ฌ๐ฎ๐๐ญ๐ฒ๐ฉ๐๐ฌ” Glioblastoma is the most aggressive primary brain tumor in adults and remains extremely difficult to treat. Oncolytic viruses, viruses that selectively infect and kill cancer cells while stimulating an anti-tumor immune response, are a promising therapeutic […]
Janne earns her PhD with promising glioblastoma research
On Friday, June 26, Janne Van Hauwenhuyse successfully defended her PhD dissertation, Identification and Development of Novel Treatment Options for Glioblastoma. Her defense was the second PhD defense in our group that week, making it a special and memorable week for the entire team. In her research, Janne evaluated FR-027, a novel Exportin 1 (XPO1) […]